BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 24412773)

  • 1. The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function.
    Xu L; Qian W; Li W; Liu J; He H; Li G; Cao Y; Yu Y
    Peptides; 2014 Feb; 52():143-8. PubMed ID: 24412773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-B-type natriuretic peptide is associated with severity of the coronary lesions in unstable angina patients with preserved left ventricular function.
    Wei G; Ningfu W; Xianhua Y; Liang Z; Jianmin Y; Guoxin T; Peng X
    J Interv Cardiol; 2012 Apr; 25(2):126-31. PubMed ID: 22150844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
    Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
    Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease?
    Kragelund C; Grønning B; Omland T; Køber L; Strande S; Steffensen R; Hildebrandt P
    Am Heart J; 2006 Mar; 151(3):712.e1-712.e7. PubMed ID: 16504637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
    Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
    Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis.
    Wolber T; Maeder M; Rickli H; Riesen W; Binggeli C; Duru F; Ammann P
    Eur J Clin Invest; 2007 Jan; 37(1):18-25. PubMed ID: 17181563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
    Hamano K; Abe M; Komi R; Kobayashi S
    Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal-proB natriuretic peptide in patients with stable coronary artery disease evaluated for ischemia with myocardial perfusion imaging.
    Majstorov V; Pop GD; Vavlukis M; Peovska I; Maksimovik J; Vaskova O; Kuzmanovska S; Zdraveska-Kochovska M
    Bratisl Lek Listy; 2008; 109(7):293-7. PubMed ID: 18792482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide and diastolic function measurements by adenosine stress echocardiography in prediction of coronary stenosis in patients.
    Zheng P; Wang H; Tian YQ; Guo YL; He ZX; Lu Y; Zheng X; Ma WJ; Xu N; Sun X; Zhang L
    Chin Med J (Engl); 2011 Jul; 124(14):2089-95. PubMed ID: 21933607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP secretion and extent of coronary artery stenosis in patients with stable coronary artery disease.
    Sakai H; Tsutamoto T; Ishikawa C; Tanaka T; Fujii M; Yamamoto T; Takashima H; Horie M
    Circ J; 2007 Apr; 71(4):499-505. PubMed ID: 17384449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary revascularization reduces plasma N-terminal pro-B-type natriuretic peptide concentration in stable coronary artery disease.
    McClure SJ; Gall S; Schechter CB; Kearney M; Zaman AG
    J Am Coll Cardiol; 2007 Jun; 49(25):2394-7. PubMed ID: 17599601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.
    Islamoglu F; Ozcan K; Apaydin AZ; Soydas C; Bayindir O; Durmaz I
    Tex Heart Inst J; 2008; 35(2):111-8. PubMed ID: 18612440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N-terminal pro-brain natriuretic peptide.
    Jian W; Mo CH; Yang GL; Li L; Gui C
    J Clin Lab Anal; 2019 Oct; 33(8):e22972. PubMed ID: 31257664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we predict the severity of coronary artery disease in patients with stable angina using NT-ProBNP?
    Yeşil M; Postaci N; Arikan E; Ceylan O; Bayata S; Köseoğlu M
    Anadolu Kardiyol Derg; 2006 Sep; 6(3):235-8. PubMed ID: 16943107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of percutaneous coronary revascularization on plasma N-terminal pro-B-type natriuretic peptide levels in stable coronary artery disease.
    Gupta A; Beig JR; Tramboo NA; Afroze D; Hafeez I; Rather HA
    Indian Heart J; 2018; 70(2):282-288. PubMed ID: 29716708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.
    Weber M; Dill T; Arnold R; Rau M; Ekinci O; Müller KD; Berkovitsch A; Mitrovic V; Hamm C
    Am Heart J; 2004 Oct; 148(4):612-20. PubMed ID: 15459591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of N-terminal pro-brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fraction.
    Wu N; Ma F; Guo Y; Li X; Liu J; Qing P; Xu R; Zhu C; Jia Y; Liu G; Dong Q; Jiang L; Li J
    Chin Med J (Engl); 2014; 127(4):627-32. PubMed ID: 24534213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-B-type natriuretic Peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes.
    Hong SN; Yoon NS; Ahn Y; Lim SY; Kim YS; Yun KH; Kang DK; Lee SH; Lee YS; Kim KH; Son IS; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Circ J; 2005 Dec; 69(12):1472-6. PubMed ID: 16308494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.